The ongoing controversy regarding mammography screening recommendations highlights the need for improved performance across the breast cancer screening process. While there is little debate that breast cancer screening can reduce breast cancer mortality, it is also clear that it is time for better approaches to screening that leverage advances in breast imaging modalities, breast cancer risk assessment and patient centered care to achieve better outcomes at lower cost. This proposal for a Penn Center for Personalized Breast Cancer Screening will advance a personalized breast cancer screening paradigm by developing a new tool (breast complexity index) for predicting individual screening outcomes, evaluating the comparative effectiveness of a new imaging modality (digital breast tomosynthesis) on screening process and outcomes, and developing effective strategies for communicating individual estimates of benefit and risk of alternative screening approaches to better link individualized information to informed patient and provider decision making. In addition to these three highly integrated research projects, the Center will bring together comprehensive screening process and outcome data on a diverse population of 74,000 women who undergo breast cancer screening at 6 sites within the PennMedlcine integrated health network. In addition to clinical, sociodemographic and screening data from EMR and screening reporting systems, this Screening Process Documentation Unit will include risk factor and other patient reported information collected through web portal and point of care surveys, screening images, cancer outcomes from state cancer registries and pathology records, patient neighborhood characteristics from the Penn Cartographic Modeling Laboratory, as well as an ongoing DNA biobank. The proposed Center leverages the substantial expertise at Penn in the multiple disciplines needed to advance a personalized screening paradigm (including breast imaging, primary care, communication, computer science, biostatistics, health services research, bioinformatics, medical oncology, and cancer genetics) as well as the commitment of the clinical leadership (including the Center Pis) to PennMedicine's role in the evaluation and implementation of such a paradigm. The Center will address questions with immediate scientific, clinical and policy impact and create an infrastructure for continuous learning about the breast cancer screening process and enabling collaboration through the PROSPR network.

Public Health Relevance

The Penn Center for Personalized Breast Cancer Screening will advance a personalized breast cancer screening by developing a new tool for predicting individual screening outcomes, evaluating the comparative effectiveness of a new imaging modality, and developing effective strategies for communicating individual screening approaches to better link individualized information to informed decision making.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163313-02
Application #
8568112
Study Section
Special Emphasis Panel (ZCA1-SRLB-R (O1))
Project Start
2012-09-01
Project End
2016-05-31
Budget Start
2012-09-01
Budget End
2013-05-31
Support Year
2
Fiscal Year
2012
Total Cost
$147,026
Indirect Cost
$54,618
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Zuckerman, Samantha P; Conant, Emily F; Keller, Brad M et al. (2016) Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology 281:730-736
Conant, Emily F; Beaber, Elisabeth F; Sprague, Brian L et al. (2016) Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat 156:109-16
Weiss, Julie E; Goodrich, Martha; Harris, Kimberly A et al. (2016) Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol :
Kim, Jane J; Tosteson, Anna Na; Zauber, Ann G et al. (2016) Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst 108:
Korhonen, Katrina E; Weinstein, Susan P; McDonald, Elizabeth S et al. (2016) Strategies to Increase Cancer Detection: Review of True-Positive and False-Negative Results at Digital Breast Tomosynthesis Screening. Radiographics 36:1954-1965
Tosteson, Anna N A; Beaber, Elisabeth F; Tiro, Jasmin et al. (2016) Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med 31:372-9
Haas, Jennifer S; Sprague, Brian L; Klabunde, Carrie N et al. (2016) Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med 31:52-9
Chen, Jane S; Sprague, Brian L; Klabunde, Carrie N et al. (2016) Take the money and run? Redemption of a gift card incentive in a clinician survey. BMC Med Res Methodol 16:25
Armstrong, Katrina; Kim, Jane J; Halm, Ethan A et al. (2016) Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer 122:1338-42
McCarthy, Anne Marie; Keller, Brad M; Pantalone, Lauren M et al. (2016) Racial Differences in Quantitative Measures of Area and Volumetric Breast Density. J Natl Cancer Inst 108:

Showing the most recent 10 out of 39 publications